Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 AUD | -3.33% | -9.38% | -23.68% |
03:46am | Nuchev Agrees to Acquire bWellness for AU$7 million; Launches AU$5.1 Million Entitlement Offer | MT |
02-26 | Nuchev Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 103.1 | 26.39 | 9.831 | 15.62 | 12.66 | - | - |
Enterprise Value (EV) 1 | 93.99 | 11.87 | 4.719 | 8.137 | 10.2 | 16.26 | 20.43 |
P/E ratio | -8.48 x | -1.96 x | -0.9 x | -1.09 x | -2.61 x | -2.94 x | -3.93 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 5.79 x | 2.42 x | 1.01 x | 1.78 x | 0.99 x | 0.8 x | 0.62 x |
EV / Revenue | 5.28 x | 1.09 x | 0.49 x | 0.93 x | 0.8 x | 1.02 x | 0.99 x |
EV / EBITDA | -9.94 x | -1.05 x | -0.46 x | -1.1 x | -2.19 x | -4.21 x | -8.09 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | 4.08 x | 0.99 x | 0.62 x | 0.75 x | 1.68 x | 3.93 x | - |
Nbr of stocks (in thousands) | 45,000 | 51,744 | 51,744 | 84,407 | 84,407 | - | - |
Reference price 2 | 2.290 | 0.5100 | 0.1900 | 0.1850 | 0.1500 | 0.1500 | 0.1500 |
Announcement Date | 8/26/20 | 8/30/21 | 8/31/22 | 8/31/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 17.8 | 10.9 | 9.724 | 8.792 | 12.73 | 15.87 | 20.57 |
EBITDA 1 | -9.453 | -11.31 | -10.18 | -7.364 | -4.666 | -3.861 | -2.527 |
EBIT 1 | -11.02 | -12.32 | -10.45 | -8.398 | -4.86 | -4.056 | -2.722 |
Operating Margin | -61.9% | -113.06% | -107.43% | -95.53% | -38.19% | -25.56% | -13.23% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - |
Net income 1 | -10.9 | -13.27 | -11.11 | -8.807 | -4.86 | -4.306 | -3.222 |
Net margin | -61.25% | -121.74% | -114.24% | -100.17% | -38.19% | -27.14% | -15.66% |
EPS 2 | -0.2700 | -0.2600 | -0.2100 | -0.1700 | -0.0576 | -0.0510 | -0.0382 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 8/26/20 | 8/30/21 | 8/31/22 | 8/31/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 3.6 | 7.77 |
Net Cash position 1 | 9.06 | 14.5 | 5.11 | 7.48 | 2.46 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -0.9328 x | -3.076 x |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | -58.4% | -51.1% | -52.3% | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | 0.5600 | 0.5200 | 0.3100 | 0.2500 | 0.0900 | 0.0400 | - |
Cash Flow per Share 2 | -0.2600 | -0.1900 | -0.1600 | -0.0600 | -0.0500 | -0.0700 | -0.0500 |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 8/26/20 | 8/30/21 | 8/31/22 | 8/31/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.68% | 8.46M | |
+5.08% | 24.69B | |
-18.48% | 8.47B | |
+0.64% | 7.12B | |
+10.12% | 6.48B | |
+3.51% | 5.56B | |
-0.89% | 5.5B | |
+5.85% | 5.29B | |
+21.66% | 5.13B | |
+21.17% | 4.51B |
- Stock Market
- Equities
- NUC Stock
- Financials Nuchev Limited